Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK-2336805 is a HCV NS5A inhibitor. GSK2336805 retained activity on chimeric replicons containing NS5A patient sequences from genotype 1 and patient and consensus sequences for genotypes 4 and 5 and part of genotype 6.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 2,270.00 | |
50 mg | 10-14 weeks | $ 2,980.00 | |
100 mg | 10-14 weeks | $ 4,000.00 |
Description | GSK-2336805 is a HCV NS5A inhibitor. GSK2336805 retained activity on chimeric replicons containing NS5A patient sequences from genotype 1 and patient and consensus sequences for genotypes 4 and 5 and part of genotype 6. |
Synonyms | GSK 2336805, GSK-2336805, JNJ-56914845, GSK-805, GSK805 |
Molecular Weight | 796.91 |
Formula | C42H52N8O8 |
CAS No. | 1256390-53-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK2336805 1256390-53-0 GSK 805 GSK 2336805 GSK-2336805 JNJ56914845 JNJ-56914845 GSK-805 GSK805 JNJ 56914845 inhibitor inhibit